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Non-traumatic myelopathies can result from a wide spectrum of conditions including 
inflammatory, ischemic, and metabolic disorders. Here, we describe the case of a 
60-year old immunocompetent woman who developed acute back pain followed by 
rapidly ascending flaccid tetraparesis, a C6 sensory level, and sphincter dysfunction 
within 8 h. Acyclovir and steroids were started on day 2 and herpes simplex virus type 
2 (HSV-2) was confirmed by polymerase chain reaction in cerebrospinal fluid. Magnetic 
resonance imaging revealed a bilateral anterior horn tractopathy expanding from C2 
to T2 and cervicothoracic cord swelling. Screening for paraneoplastic antibodies and 
cancer was negative. Neurophysiology aided in the work-up by corroborating root 
involvement. Recovery was poor despite early initiation of antiviral treatment, adjuvant anti- 
inflammatory therapy, and neurorehabilitation efforts. The clinical course, bilateral affection 
of the anterior horns, and early focal atrophy on follow-up magnetic resonance imaging 
take a necrotizing myelitis potentially caused by intraneuronal spread of the virus into 
consideration. Further, we summarize the literature on classical and rare presentations 
of HSV-2 myeloradiculitis in non-immunocompromised patients and raise awareness for 
the limited treatment options for a condition with frequent devastating outcome.
Keywords: infectious myelitis, herpes simplex virus type 2, longitudinally extensive transverse myelitis, 
myeloradiculitis, treatment, outcome
INtRoDUCtIoN
Longitudinally extensive transverse myelopathy (LETM) describes the condition of a hyperintense 
spinal cord lesion extending over three or more vertebral levels on sagittal T2-weighted magnetic 
resonance imaging (MRI). While neuromyelitis optica spectrum disorder (NMOSD) is among the 
most frequent causes worldwide, a number of other disorders can manifest as or develop LETM 
over time and have risk of recurrence (1). Thus, a timely diagnosis is driven by the efforts to provide 
early and appropriate treatment, set measures to prevent future attacks, and avoid severe disability 
(2). In this regard, the differential diagnosis of LETM beyond NMOSD included multiple sclerosis, 
FIgURe 1 | (a) Sagittal T2-weighted magnetic resonance imaging (MRI) of the cervicothoracic spinal cord on admission showed a hyperintense “pencil-like” lesion 
at the level of the anterior horn which extends from the level of the second cervical to second thoracic vertebral level (red arrowheads) and cord swelling in large 
parts of the affected area. (B,C) Follow-up T2-weighted MRI 9 weeks later revealed a less homogenous hyperintense filiform signal in the anterior region of the 
cervicothoracic cord and circumscribed medullar atrophy in the sagittal plane (red arrowheads). The axial MRI is at the C5 level and demonstrates bilateral 
hyperintensive signals involving the anterior horns of both sides (owl’s eye appearance, red arrowheads).
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acute disseminated encephalomyelitis, parainfectious disorder, 
subacute combined degeneration, tuberculous myelitis, spinal 
arteriovenous malformation, and systemic lupus erythematosus 
in a recent study (3).
Herpes simplex virus type 2 (HSV-2) is a neurotropic virus 
which can cause genital herpes, aseptic meningitis, encephalitis 
and myelitis, and devastating infections of the neonate. The belief 
that the virus reactivates in lumbosacral ganglia is challenged by 
animal experiments, which found that autonomic ganglia and 
the spinal cord could be another latency site. Moreover, Ohashi 
and coworkers showed that HSV-2 reaches dorsal root ganglia 
and spinal cord independently (4). Myelitis related to HSV-2 is 
a rare entity and mostly reported in patients with malignancy 
and acquired immune deficits (5). The classical course of HSV-2 
myelitis is ascending myelopathy with subacute development of 
cervicothoracic sensorimotor impairment. However, fulminant 
and less rapidly progressing cases have been reported as well (6).
Case RepoRt
A 60-year-old woman developed acute back pain and urinary reten-
tion. Ascending sensorimotor disturbances developed thereafter 
and reached a plateau after 8  h. The neurological examination 
revealed severe tetraparesis and a sensory C6 level. Deep tendon 
reflexes were absent in the upper limbs and plantar responses 
were both extensor. The urodynamic study showed atonic 
contraction. Spinal cord MRI demonstrated a “pencil-like” T2 
lesion expanding from C2 to T2 in the anterior part of the sagit-
tal plane and swelling of the cervicothoracic cord (Figure 1A). 
Follow-up examination continued to demonstrate a cervicotho-
racic fusiform lesion in addition to focal atrophy and cavitation 
(Figures  1B,C). Brain MRI was unremarkable. Cerebrospinal 
fluid (CSF) analysis showed a normal cell count (2  cells/ml), 
elevated protein (76  mg/dl), normal glucose levels (65  mg/dl), 
and IgG index 0.49. Bacterial and fungal cultures were negative, 
and CSF-specific oligoclonal bands were absent. The test for 
anti-HSV antibody (ELISA) in the CSF showed positive IgM-HSV 
(2,000 mg/dl) and negative IgG-HSV. HSV-2 DNA was detected 
by polymerase chain reaction (PCR) in CSF (50 copies/μl). Other 
PCR examinations including varicella-zoster virus and enterovi-
rus were negative. Dermatological manifestations did not occur 
during the entire course. Blood testing for antibodies against 
aquaporin-4, antinuclear antibodies, anti-neutrophil cytoplasmic 
antibodies, paraneoplastic antibodies, and HIV were negative. 
Further unremarkable blood tests included serum protein 
electrophoresis, angiotensin-converting enzyme vitamin B12, 
and erythrocyte sedimentation rate. Cancer was ruled out by 
appropriate measures.
Treatment with intravenous acyclovir (10 mg/kg body weight 
three times daily) was started on the second day of admis-
sion, 4  days in conjunction with betamethasone (8  mg/day). 
Compound action potentials (cMAPs) and nerve motor conduc-
tion velocity were within normal limits on day 2. F-waves were 
absent in all tested nerves of upper limb and lower limbs, whereas 
the sensory nerve conduction study was normal. This finding sug-
gested a damage to the anterior horn motor neurons and ventral 
root fibers. Ten weeks later, neurography showed a severe and 
inhomogeneous amplitude reduction and absence of cMAPs with 
relatively preserved conduction velocity in all tested nerves as well 
as the appearance in some nerves of impersistent and low-voltage 
F-responses. This confirmed secondary axonal loss in all motor 
nerves. Electromyography revealed a subacute neuropathic pat-
tern with widespread denervation, minimally altered motor unit 
action potentials (MUAPs) morphology, and decreased recruit-
ment in the upper limb muscles with different degree of severity. 
In the examined muscles of the lower limbs, spontaneous activity 
was less evident and MUAPs recruitment was absent, thus reflect-
ing a reduced central drive.
The neurological examination 3  months later revealed a 
moderate degree flaccid weakness of the upper limbs, a severe 
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taBLe 1 | Herpes simplex virus type 2 (HsV-2) myelitis in non-immunocompromised patients: overview of cases studied by polymerase chain reaction (pCR) of cerebrospinal fluid (CsF) specimen.
Case no. Reference Demographics 
(gender, years 
of age)
Comorbidity HsV-2 pCR in 
CsF (copies/μl)
Dynamics and 
clinical syndrome
additional 
manifestations
CsF (cells/μl, 
protein mg/dl)
Longitudinal and 
axial magnetic 
resonance imaging 
lesion expansion
Herpetic 
skin lesions
treatment outcome at 
discharge
1 (8) Female, 76 n.r. Positive Subacute, 
paraplegia, bladder 
dysfunction, T10 
level
Radiculitis 73, 132 T10-conus, 
enhancement of 
meninges and roots
Buttocks, 
tights, 
abdomen
Acyclovir Died 21 days from 
admission
2 (13) Female, 49 n.r. Positive Acute (sudden), 
paraplegia, back 
pain, urinary 
retention, T5/T7 
level
Relapse of 
myelitis
30, 79 C2, posterior (at 
relapse)
No Acyclovir, 
steroids
Complete recovery
3 (13) Male, 38 n.r. Positive Subacute 
(1 month), 
paraparesis, 
bladder 
dysfunction, T6 
level
Relapse of 
myelitis
11, 75 Normal at relapse Genital at 
relapse
Acyclovir, 
steroids
Paraparesis
4 (9) Male, 44 Diabetes Positive Acute (1 week), 
paraparesis, urinary 
problems, T4 level
105, 122 Not performed Genital Acyclovir on 
day 5, steroids
Paraplegia
5 (9) Male, 69 n.r. Positive Acute (1 week), 
paraparesis, urinary 
problems, T3 level
Encephalitis 52, 72 T7–L No Acyclovir 
on day 5, 
vidarabine, 
steroids, IVIG
Tetraplegia
6 (9) Female, 50 n.r. Positive Acute (1 week), 
paraparesis, urinary 
problems, T5 level
39, 51 T7–L No acyclovir on day 
7, vidarabine, 
steroids
Paraplegia
7 (9) Female, 50 n.r. Positive Acute (2 weeks), 
paraparesis, urinary 
problems, T4 level
158, 99 C–L No Acyclovir on 
day 12,  
steroids
Paraplegia
8 (9) Male, 68 n.r. Positive Acute (2 weeks), 
paraparesis, urinary 
problems, T10 level
3, 51 T5–9 No Acyclovir after 
3 months, 
steroids
Recovery
9 (9) Male, 38 n.r. Positive Subacute 
(3 months), paresis 
of left lower limb, 
urinary problems, 
T7 level
Relapse of 
myelitis
11, 75 Not performed Genital Acyclovir after 
4 months, 
steroid
Paraplegia
10 (9) Female, 49 n.r. Positive Subacute 
(4 months), paresis 
of right lower limb, 
urinary problems, 
T6 level
Relapse of 
myelitis
196, 90 C2–4, posterior 
funiculus
No Acyclovir on 
day 7, steroids
Recovery
(Continued )
4Nardone et al. HSV-2 Myelitis
Frontiers in Neurology | www.frontiersin.org May 2017 | Volume 8 | Article 199
spastic paraparesis and a distended bladder. Now, a sensory level 
was not evident.
DIsCUssIoN
Infratentorial, spinal cord, and peripheral nervous system mani-
festations of HSV-2 are a relative rarity (7). A Pubmed-search 
for PCR-confirmed HSV-2 myelitis in non-immunosuppressed 
patients revealed 11 cases with varying clinical presentation, MRI 
and CSF findings, dermatological manifestations, chances for 
recurrence, and persistent neurological deficits (Table 1). Acute, 
subacute, and ascending progressive courses were present, the 
ascending necrotizing form is presumably the most devastating 
subtype (8). Most patients received steroids with varying duration 
and success on outcome. Yet, some authors assume that this treat-
ment is the mainstay for attenuating immune-mediated damage 
and halting further disease progression (9). This hypothesis goes 
back to the observation by Klastersky who reported not only large 
necrotic areas in the anterior horn and posterior fiber tracts but also 
multiple demyelinated areas in the white matter in an autopsy case 
of HSV-2 myelitis (10). The literature search for PCR-confirmed 
HSV-2 myelitis cases revealed that spinal cord lesions are more 
frequently located within the thoracolumbar section, and genital 
herpetic skin lesion are found in a few. A report of a patient series 
with mostly autopsy-confirmed cases corroborated a rare occur-
rence of a rash and further disclosed that fever is rare during both 
onset and progression of the disease (6). Cervical MRI lesions 
have also been reported with HSV-2 and occasionally in form of 
LETM. However, anterior horn tractopathy as seen in our case 
has not been observed among the published HSV-2 cases so far. 
In contrast, a pediatric case with polio-like presentation caused by 
HSV-1 was published in 1993 (11). HSV-2 myelitis is assumed to 
result from virus reactivation, which was latent in dorsal root gan-
glia (12). It is tempting to speculate intraneural spread of HSV-2 
along anterior horn over a large area of the cervicothoracic cord 
may have been involved in the pathophysiology of our case. The 
subsequent focal spinal cord degeneration despite early initiation 
of antiviral and anti-inflammatory therapy is impressive and calls 
for more research in this condition to examine the pathophysi-
ological basis and treatment options.
A more stroke-like presentation as in our case was reported 
for one other report (case #2). Indeed, our case does share some 
clinical and radiological features of spinal cord infarction (15). 
The extent of longitudinal expansion, however, does not fit into 
the concept for vascular supply of the spinal cord and is not 
reported in the most comprehensive prospective study on spinal 
cord infarction (16). HSV-2 can cause cerebral ischemia and hem-
orrhage due to vasculitis (17). As ischemic necrosis is a known 
neuropathological feature of HSV-2 myelitis, an involvement of 
vasculitis could be translated to the pathogenesis of the disease 
(10). It needs to be stressed that most tractopathies are seen with 
parainfectious or paraneoplastic disorders, or infections, such 
as poliomyelitis, West Nile virus encephalomyelitis, and tick-
borne encephalitis (18–20). All these conditions were ruled out. 
Moreover, neurophysiology is crucial for identifying, quantifying, 
and monitoring radicular involvement. A contrast-enhanced spi-
nal MRI, however, would have been ideal to further characterize Ca
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the current case and exclude additional differential diagnoses, 
including primary CNS vasculitis of the spinal cord (21).
There are efforts to rationalize the PCR testing for HSV based 
on CSF cell count and protein levels. Our patient had a normal 
cell count but elevated protein in CSF and met the Hansen cri-
teria with demand elevated CSF leukocyte count (>5/μl) and/or 
protein levels (>50 mg/dl) (22). The exception to this guidance 
includes patient’s age (<2 years) and altered host immune status. 
PCR results need to be interpreted in the context of the patient’s 
clinical presentation and timing of the CSF sampling (23). Indeed, 
the low viral load needs to be seen in the context of early admis-
sion, relatively small lesion size, and limited direct CSF contact.
CoNCLUsIoN
We report the case of a cervicothoracal tractopathy with stroke-
like presentation caused by HSV-2. Outcome was poor despite 
early antiviral and anti-inflammatory treatment. We conclude 
that there is need for further neuropathological characterization 
of the condition and international prospective patient registries, 
ideally including multimodal treatment concepts.
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